Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivan Foeldvari

Showing results (11-20 of 174) with videos related to

Pageof 18
Sort By:
The Journal of Rheumatology|May 18, 2010
Effectiveness of leflunomide in patients with juvenile idiopathic arthritis in clinical practiceIvan Foeldvari, Angela Wierk
The Journal of Rheumatology|February 5, 2005
Methotrexate is an effective treatment for chronic uveitis associated with juvenile idiopathic arthritisIvan Foeldvari, Angela Wierk
Best Practice & Research. Clinical Rheumatology|April 26, 2021
Review for best practice in clinical rheumatology juvenile systemic sclerosis - Updates and practice pointsIvan Foeldvari, Kathryn S Torok
Rheumatic Diseases Clinics of North America|April 7, 2023
Approach to Systemic Sclerosis Patient Assessment: How Does Patient Subsetting Help?Sindhu R Johnson, Ivan Foeldvari
Pediatric Rheumatology Online Journal|January 20, 2025
Reducing the risk of visual disability for children with juvenile idiopathic arthritis uveitis through disease surveillance: past and future challengesAmeenat Lola Solebo, Ivan Foeldvari
Best Practice & Research. Clinical Rheumatology|February 4, 2026
Juvenile systemic sclerosisIvan Foeldvari, Clare E Pain
Clinical and Experimental Rheumatology|June 15, 2021
Secukinumab in the treatment for patients with juvenile enthesitis related arthritis non-responsive to anti-TNF treatment according the Juvenile Spondyloarthritis Disease Activity IndexJean Baer, Jens Klotsche, Ivan Foeldvari
Journal of Scleroderma and Related Disorders|April 6, 2022
Assessing the prevalence of juvenile systemic sclerosis in childhood using administrative claims data from the United StatesTimothy Beukelman, Fenglong Xie, Ivan Foeldvari
Arthritis Care & Research|May 20, 2015
Uveitis Events During Adalimumab, Etanercept, and Methotrexate Therapy in Juvenile Idiopathic Arthritis: Data From the Biologics in Pediatric Rheumatology RegistryIvan Foeldvari, Ingrid Becker, Gerd Horneff
Journal of Scleroderma and Related Disorders|April 6, 2022
The prevalence of localised scleroderma in childhood assessed in the administrative claims data from the United StatesTimothy Beukelman, Fenglong Xie, Ivan Foeldvari
Pageof 18

Showing results (11-20 of 174) with videos related to

Sort By:
Pageof 18
The Journal of Rheumatology|May 18, 2010
Effectiveness of leflunomide in patients with juvenile idiopathic arthritis in clinical practiceIvan Foeldvari, Angela Wierk
The Journal of Rheumatology|February 5, 2005
Methotrexate is an effective treatment for chronic uveitis associated with juvenile idiopathic arthritisIvan Foeldvari, Angela Wierk
Best Practice & Research. Clinical Rheumatology|April 26, 2021
Review for best practice in clinical rheumatology juvenile systemic sclerosis - Updates and practice pointsIvan Foeldvari, Kathryn S Torok
Rheumatic Diseases Clinics of North America|April 7, 2023
Approach to Systemic Sclerosis Patient Assessment: How Does Patient Subsetting Help?Sindhu R Johnson, Ivan Foeldvari
Pediatric Rheumatology Online Journal|January 20, 2025
Reducing the risk of visual disability for children with juvenile idiopathic arthritis uveitis through disease surveillance: past and future challengesAmeenat Lola Solebo, Ivan Foeldvari
Best Practice & Research. Clinical Rheumatology|February 4, 2026
Juvenile systemic sclerosisIvan Foeldvari, Clare E Pain
Clinical and Experimental Rheumatology|June 15, 2021
Secukinumab in the treatment for patients with juvenile enthesitis related arthritis non-responsive to anti-TNF treatment according the Juvenile Spondyloarthritis Disease Activity IndexJean Baer, Jens Klotsche, Ivan Foeldvari
Journal of Scleroderma and Related Disorders|April 6, 2022
Assessing the prevalence of juvenile systemic sclerosis in childhood using administrative claims data from the United StatesTimothy Beukelman, Fenglong Xie, Ivan Foeldvari
Arthritis Care & Research|May 20, 2015
Uveitis Events During Adalimumab, Etanercept, and Methotrexate Therapy in Juvenile Idiopathic Arthritis: Data From the Biologics in Pediatric Rheumatology RegistryIvan Foeldvari, Ingrid Becker, Gerd Horneff
Journal of Scleroderma and Related Disorders|April 6, 2022
The prevalence of localised scleroderma in childhood assessed in the administrative claims data from the United StatesTimothy Beukelman, Fenglong Xie, Ivan Foeldvari
Pageof 18